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Background: Small RNAs complex with proteins to mediate a variety of functions in animals and plants. Some
small RNAs, particularly miRNAs, circulate in mammalian blood and may carry out a signaling function by entering
target cells and modulating gene expression. The subject of this study is a set of circulating 30–33 nt RNAs that are
processed derivatives of the 5′ ends of a small subset of tRNA genes, and closely resemble cellular tRNA derivatives
(tRFs, tiRNAs, half-tRNAs, 5′ tRNA halves) previously shown to inhibit translation initiation in response to stress in
cultured cells.
Results: In sequencing small RNAs extracted from mouse serum, we identified abundant 5′ tRNA halves derived
from a small subset of tRNAs, implying that they are produced by tRNA type-specific biogenesis and/or release. The
5′ tRNA halves are not in exosomes or microvesicles, but circulate as particles of 100–300 kDa. The size of these
particles suggest that the 5′ tRNA halves are a component of a macromolecular complex; this is supported by the
loss of 5′ tRNA halves from serum or plasma treated with EDTA, a chelating agent, but their retention in plasma
anticoagulated with heparin or citrate. A survey of somatic tissues reveals that 5′ tRNA halves are concentrated
within blood cells and hematopoietic tissues, but scant in other tissues, suggesting that they may be produced by
blood cells. Serum levels of specific subtypes of 5′ tRNA halves change markedly with age, either up or down, and
these changes can be prevented by calorie restriction.
Conclusions: We demonstrate that 5′ tRNA halves circulate in the blood in a stable form, most likely as part of a
nucleoprotein complex, and their serum levels are subject to regulation by age and calorie restriction. They may be
produced by blood cells, but their cellular targets are not yet known. The characteristics of these circulating
molecules, and their known function in suppression of translation initiation, suggest that they are a novel form of
signaling molecule.
Keywords: Aging, Calorie restriction, Circulating small RNAs, tRNA derivatives, tRNA halves, Serum, PlasmaBackground
Several classes of small RNAs have been found to mediate
biological functions in animals and plants [1-5]. miRNAs,
siRNAs, piRNAs, and others are bound by Argonaute pro-
teins, and have the common property of directing protein
complexes to nucleic acids with sequence complementar-
ity, where they may cleave or otherwise alter the target [6].* Correspondence: jdhahbi@ucr.edu
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reproduction in any medium, provided the orIn both plants and animals, some small RNAs are able
to travel between tissues within an organism, thus trans-
ferring their functions to other cells. In vertebrates, there
has been much recent interest in the presence of spe-
cific miRNAs in the plasma and serum; there is some
evidence that these can be taken up by cells and alter
gene expression, and there is also interest in the possi-
bility that they can be markers of specific disease states,
including cancer [7-9].
There is also evidence for processing of non-coding
RNAs into smaller RNAs, many with as yet poorlyLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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http://www.biomedcentral.com/1471-2164/14/298understood functions [10,11]. Many of the non-coding
RNAs that appear to undergo processing into smaller
RNAs have well studied functions, although their smaller
derivatives often do not. In particular, tRNA is processed
into shorter forms termed tRNA fragments (tRFs)
[12,13]. The subject of this report is a tRNA fragment
created by cleavage of tRNA near the anticodon loop to
create a ″5′ tRNA half” (the term we will use here). Pre-
vious reports have described 5′ tRNA halves as intracel-
lular molecules interacting with components of the
translation initiation complex. 5′ tRNA halves have been
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Figure 1 Length distribution of reads obtained by deep sequencing o
those reads that map to the mm10 (GRCm38) mouse genome. (A) Length d
from 9 serum samples. Reads were mapped to the mouse genome with bo
disallowing (red bars) multiple reportable alignments for each read. (B) Com
according to the end-to-end k-difference policy, either allowing (blue bars)
(C) Length distribution of separate sequencing reads obtained from 9 indivi
abundance of sequencing reads that were mapped to the mouse genome
reportable alignments for each read. Bars with different colors denote the sresponse to stress in cultured cells, to promote assembly
of stress granules carrying stalled preinitiation com-
plexes, and to inhibit mRNA translation [14,15]; little
more is known about their function.
We have sequenced small RNAs present in mouse
serum; when multiple reportable alignments of the sequen-
cing reads to the mouse genome were allowed, we noted
the presence of a class of tRNA-derived 30–33 nt frag-
ments that closely resemble the 5′ tRNA halves previously
described in stressed cell cultures. Investigation of these 5′
tRNA halves reveals a novel class of circulating small
RNAs whose characteristics, including changes with age 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 
 (nucleotides)
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f small RNAs extracted from mouse serum. Shown here are only
istribution is displayed by abundance of sequencing reads combined
wtie according to Maq’s default policy, either allowing (blue bars) or
bined reads were mapped to the mouse genome with bowtie
or disallowing (red bars) multiple reportable alignments for each read.
dual serum small RNA samples. Length distribution is displayed by
with bowtie according to Maq’s default policy, and allowing multiple
ource of the sequenced serum small RNA from the 9 different samples.
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physiologic regulation and function.
Results and discussion
Sequencing and computational analysis of small RNAs
circulating in mouse serum
While investigating the effects of aging and calorie re-
striction (CR) on the profiles of cell-free small RNAs cir-
culating in the bloodstream, we used small RNA-Seq
(Illumina reads of 50 nt) to compare the serum levels of
small RNAs from young and old control mice, and old
mice subjected to CR. A combined total of 196,083,881
pre-processed sequencing reads obtained from 9 differ-
ent serum samples, were mapped to the mouse genome
with bowtie using parameters that align reads according
to a policy similar to Maq’s default policy [16]. Align-
ment of the combined 196,083,881 pre-processed se-
quencing reads generated a dataset of 163,078,230
mapped reads (83.2%), ranging from 5 to 48 nt. The
size distribution of the mapped reads revealed an
expected peak at 20–24 nt consistent with the size of
miRNAs (Figure 1).
Only if multiple reportable alignments are allowed






























Figure 2 Annotation of combined sequencing reads of small RNAs ex
abundance of the total reads mapped to the mouse genome (black bars),
(blue bars), rRNAs (green bars), or other small RNAs (yellow bars). Other sm
20–24 nt and the 30–33 nt peaks are almost exclusively annotated as miRN
reads mapping to the specific types of small RNAs. (C) Frequencies of 5′ tRemerge at 30–33 nt (Figure 1A). The 30–33 nt peak per-
sists when the bowtie alignment mode is changed from
the Maq’s default policy (n option) to the end-to-end k-
difference policy (v option), but again disappears when
multiple reportable alignments are suppressed (Figure 1B).
The same two-peak pattern was observed when the 9 indi-
vidual sequenced serum small RNA samples were mapped
to the mouse genome (Figure 1C). Dependence of the 30–
33 nt peak on multiple reportable alignments indicates that
the reads are encoded by repetitive DNA. Six percent of
the 163,078,230 mapped reads, aligned to a group of
RepeatMasker classes (DNA, LINE, LTR, Low complexity,
RC, SINE, Satellite, and Simple repeat); these reads were
mainly < 20 nt in size (Additional file 1: Figure S1) and
were not considered for further analysis.
Annotation analysis of the mapped sequencing reads
revealed that the 30–33 nt peak consists of reads map-
ping to tRNA genes (Figure 2A), which are present in
multiple copies in the genome. Reads in the 20–24 nt
peak were mostly annotated as miRNAs. Further analysis
showed that of the total 163,078,230 reads that mapped
to the mouse genome, 128,703,415 (79%) map to se-
quences encoding small RNAs, of which 67% and 31%
were annotated as tRNAs and miRNAs, respectivelyVal (44%)
Gly (46%)
His (1%)
Other tRNAs (1%)Glu (8%)
(C)
ucleotides)
  27       28       29        30       31       32     33      34
tracted from 9 mouse serum samples. (A) Length distribution by
with reads annotated as mapping to either miRNAs (red bars), tRNAs
all RNAs include scRNA, snRNA, and srpRNA. Note that the reads in the
As and tRNAs, respectively. (B) A pie chart showing the percentage of
NA half types represented in the aligned reads.
(A)
(B)
Figure 3 UCSC genome browser screenshots illustrating alignment of reads to two tRNA genes. Shown are the Illumina sequencing reads
(red), and the tRNA genes (blue) as annotated in the tRNA genes track ”Transfer RNA genes identified with tRNAscan-SE“. (A) The alignment
(number of reads, y-axis) shows that all the sequencing reads align to the 5′ end of chr1.tRNA704-GlyGCC gene. (B) The majority of the sequencing
reads align to the 5′ end of chr11.tRNA945-ArgCCG gene, whereas only a very small number of sequencing reads aligns to the 3′ end.
Table 1 Total number and percentage of the different
sizes of sequencing reads that map to tRNAs
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quences annotated as encoding rRNA and other small
RNAs (scRNA, snRNA, srpRNA).
Characterization of circulating small RNAs derived
from tRNAs
Since the 86,343,437 reads that align to tRNA genes are
only 30 to 33 nt, and thus do not represent full length
tRNAs, we examined the tRNA end distribution of the
reads, and annotated the reads based on their overlap
with 5′ or 3′ ends of tRNAs. More than 99% of the
tRNA-derived reads align with the 5′ end of a tRNA;
this is exemplified in Figure 3 for two tRNA genes.
23%, 17%, 35%, and 26% of the sequencing reads that
map to tRNAs are 30, 31, 32, and 33 nucleotide in size,
respectively (Table 1), indicating that full length tRNAs
are cleaved in the anticodon loop at more than one site
and at varying rates to generate the 5′ tRNA halves
found in serum. As an example, Figure 4 depicts the size
frequency of reads mapping to the 5′ end of the chr1.
tRNA704-GlyGCC gene; this indicates that this tRNA is
cleaved at different rates and at 4 different sites located
upstream of the GCC anticodon in the anticodon loop.It is unlikely that this result is a sequencing artifact: the
full length of most tRNAs is 75–90 nt, and the sequen-
cing runs used to generate these data were 50 cycles
while the reads occupy a narrow size range of 30–33 nt.
This pattern suggests that the tRNA reads were derived
from processed fragments of full length tRNAs; the re-
mainder of the tRNA was not significantly detected in
the serum small RNA libraries. In support of this conclu-
sion, tRNAs have been shown to undergo cleavage within
anticodon loops to produce tRNA-derived stress-induced
fragments (tiRNAs) when cultured cells are subjected to
stresses such as arsenite, heat shock, or ultraviolet irradi-









Figure 4 Cleavage sites of tRNAs. The cloverleaf structure of chr1.tRNA704-GlyGCC gene (downloaded from http://gtrnadb.ucsc.edu) showing
cleavage sites at the anticodon loop, with the percentage of the reads that map to the 5′ end of the tRNA (arrowheads). The cleavage sites are
upstream of the GCC anticodon located at nucleotides 33 to 35. Numbers inside the anticodon loop indicate anticodon nucleotides positions.
Table 2 Frequencies of circulating 5′ tRNA halves and the
gene copy number of tRNAs from which the tRNA halves
were derived





Others* 351 < 1%
* All the remaining tRNAs combined.
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cause the generated 5′ tRNA fragments are stable in
the cell. Our findings indicate that tRNA fragments
highly similar to tiRNAs are present under normal
(unstressed) conditions, and can remain stable even after
they are released into the peripheral blood. 5′ but not 3′
tRNA fragments inhibit mRNA translation initiation in
cultured cell lines [18].
The individual 5′ tRNA halves present in serum are
derived from a small subset of tRNAs (Figure 2C). The
most abundant circulating tRNA halves were derived
from the isoacceptors of glycine (46%), valine (44%), glu-
tamine (8%), and histidine (1%), and the remaining
amino acids together represented <1%. We contrasted
the number of tRNA genes in the Genomic tRNA Data-
base [19], with the relative abundances of the circulating
5′ tRNA halves, and found no correlation (Table 2). Forexample, the most abundant circulating 5′ tRNA halves
were derived from tRNA-Gly, and the copy number of
tRNA-Gly gene is 29; on the other hand tRNA-Cys
genes, with a copy number of 57, generate <1% of the 5′
tRNA-Cys halves.
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release of the circulating 5′ tRNA halves.
Presence in circulating mouse blood of particles
containing stable cell-free 5′ tRNA halves
To obtain an independent validation of the sequencing
results, we used Northern blotting to analyze small
RNAs circulating in the mouse serum. As a positive con-
trol for detection of tRNA halves by Northern blotting,
we included RNA from U2OS cells cultured in the ab-
sence or presence of sodium arsenite, which is known to
generate tRNA halves in these cells [18]. We probed RNA
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Figure 5 Detection of 5′ tRNA halves in mouse serum. Northern blot an
presence (+) of sodium arsenite (AS), or from 0.4 ml of mouse serum. The b
complementary to the 5′ (A) or 3′ end (B) of tRNA-Gly-GCC. The blot was als
complementary to the 5′ (C) or 3′ end (D) of tRNA-Val-CAC. 5′ tRNA halves w
analysis was carried out on RNA extracted from either 0.4 ml of mouse who
of mouse serum at 110000g, or the ultracentrifugation pellet. The blot was
to the 5′ (E) or 3′ end (F) of tRNA-Gly-GCC. (G) Ultrafiltration indicates a size
serum mixed with 1.8 ml PBS were subjected to ultrafiltration through Vivas
extracted from filtrate (f) and concentrate (c) fractions. Blot was hybridized t
of tRNA-Gly-GCC. The positions of full length tRNAs and tRNA halves are indto 5′ or 3′ ends of specific tRNAs. Probes specific for the
5′ ends of tRNA-Gly-GCC or tRNA-Val-CAC detected a
band migrating near the 30 nt RNA marker (Figure 5A
and C) confirming the presence of stable circulating
5′ tRNA halves. No significant bands migrated with
the 30 nt RNA marker when the same Northern blot
was probed for the 3′ end of tRNA-Gly-GCC or tRNA-
Val-CAC (Figure 5B and D).
We also probed RNA from mouse serum with a probe
complementary to the 5′ end of tRNA-Asn-GTT to con-
firm the low abundance of circulating tRNA halves de-
rived from tRNAs that were barely detected in the
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lot was hybridized to a 32P-end-labeled oligonucleotide probe
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ere also detected in fractionated mouse serum. (E-F) Northern blotting
le serum, from the supernatant (Sup) after ultracentrifugation of 0.4 ml
hybridized to a 32P-end-labeled oligonucleotide probe complementary
for tRNA serum particles between 100 and 300 kDa. Samples of 0.2 ml
pin 2 columns with 30, 100, and 300 kDa MW cut-offs. Total RNAs were
o 32P-end-labeled oligonucleotide probes complementary to the 5′ end
icated on the right. DM: decade markers.
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pared to the strong signal from the tRNA-Gly-GCC
probe obtained after a short (25 minute) exposure (Add-
itional file 1: Figure S2). These results are consistent
with the sequencing, and inconsistent with a sequencing
bias. They imply a tRNA type-specific biogenesis and/or
release of the circulating 5′ tRNA halves.
We next asked if the 5′ tRNA halves are contained
within circulating exosomes or microvesicles. We
Northern blotted RNA extracted from pellet or super-
natant after ultracentrifugation of mouse serum at
110000g for 2 hours. A probe for the 5′ end of tRNA-
Gly-GCC detected an ~30 nt band present mainly in
the supernatant and visible only as a trace in the pel-
let (Figure 5E), while a probe for the 3′ end did not
detect any significant signal (Figure 5F). Identical re-
sults were obtained for the 5′ end of tRNA-Val-CAC
(Figure 6A). These findings indicate that the 5′tRNA
halves are mostly not included in exosomes or micro-
vesicles, which would pellet in these conditions. Simi-
larly, exosome encapsulation is not required for the
stability of circulating miRNAs; after pelleting exosomes by
ultracentrifugation of plasma, miRNAs were still detected
in the supernatant fraction [20,21].
Because the tRNA halves we observe are stable in cir-
culation but not encapsulated in exosomes, they are
most likely complexed to carrying factors (e.g., proteins
that protect them from degradation). To determine the
size range of the putative complexes carrying the 5′
tRNA halves in the serum, we Northern blotted RNA
extracted from concentrate or filtrate fractions afterSerum











Figure 6 Northern blotting analysis of tRNA-Val-CAC halves in mouse
supernatant or pellet after ultracentrifugation of 0.4 ml of mouse serum at
5′-end labeled oligonucleotide probe complementary to the 5′ end of tRNA
subjected to ultrafiltration with Vivaspin 2 columns with 30, 100, and 300 k
concentrate (c) fractions. Blot was hybridized to a 32P 5′-end labeled oligon
positions of full length tRNAs and tRNA halves are indicated on the right. Dultrafiltration of mouse serum samples through Vivaspin
2 columns with 30, 100, or 300 kDa MW cut-off. A
probe for the 5′ end of tRNA-Gly-GCC detected a ~30 nt
band in the concentrates of 30 and 100 kDa MW cut-off,
and in the filtrate of 300 kDa MW cut-off (Figure 5G).
Identical results were obtained for the 5′ end of tRNA-
Val-CAC (Figure 6B).
Thus 5′ tRNA halves circulate as part of 100–300 kDa
complexes, while the 5′ tRNA halves themselves are
only ~10 kDa. This is reminiscent of reports that
miRNAs can circulate in the bloodstream as components
of RNA-protein/lipoprotein complexes. Stable argonaute2-
miRNA complexes that are not part of microvesicles were
recovered from plasma and serum, and high-density lipo-
protein has been reported to carry and deliver miRNAs
to recipient cells [20-22].
5′ tRNA halves are concentrated in hematopoietic and
lymphoid tissues
To investigate whether 5′ tRNA halves are present in
tissues we extracted total RNA from liver, spleen, and
testes, and did Northern blots with probes complemen-
tary to 5′ and 3′ ends of tRNAs. We detected tRNA
halves with a probe complementary to the 5′ end of
tRNA-Gly-GCC in the spleen, but not in the liver and
testes; a probe for the 3′ end tRNAs detected only full
length tRNAs in all 3 tissues (Figure 7A-B). This
prompted us to explore the possibility that 5′ tRNA
halves are present specifically in hematopoietic tissues.
Northern blotting of several mouse tissues confirmed
that 5′ tRNA halves are present in hematopoietic and-tRNA halves
B (5’ probe)
  c    f     c     f     c 
Da 100kDa 300kDa
serum. (A) RNA extracted from 0.4 ml of mouse whole serum, from
110000g and analyzed with northern blotting by hybridization to a 32P
-Val-CAC. (B) RNA extracted from 0.2 ml serum mixed with 1.8 ml PBS
Da MW cut-off. Total RNAs were extracted from filtrate (f) and










D (3’ probe)C (5’ probe)
DM DM






F (3’ probe)E (5’ probe)
DM
Figure 7 Tissue distribution of tRNA-Gly-GCC halves. Northern blotting analysis of RNA extracted from the indicated mouse tissues. Blots
were hybridized with 32P-end-labeled oligonucleotide probes complementary to the 5′ (A, C, and E) or 3′ end (B, D, and F) of tRNA-Gly-GCC. The
positions of full length tRNAs and tRNA halves are indicated on the right. DM: decade markers.
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liver, leukocytes, bone marrow, and thymus, but almost
absent in non-immune tissues including testes, liver,
heart, brain, and kidney (Figure 7); the presence of 3′
tRNA halves was not significant in any tissue. This find-
ing is consistent with a previous report [23], in which
tRNA halves were unexpectedly detected on cloning of
microRNAs from human fetal liver, which is the main
hematopoietic organ during fetal development. Identical
results were obtained when the same Northern blots
were probed for the 5′ and 3′ ends of tRNA-Val-CAC
(Figure 8).
More extensive studies will establish if 5′ tRNA halves
are concentrated in particular blood cell types, although
the very high levels in lymph nodes point to lympho-
cytes as one such type. The evidence does not establish
whether the 5′ tRNA halves are concentrated in
hematopoietic cells because they are produced there, or
because they are preferentially taken up from the blood:neither the origin nor the destinations of the 5′ tRNA
halves is certain. The low levels of 5′ tRNA halves
present in non-hematopoietic tissues may indicate low
levels in those tissues, but they may also be derived from
residual blood cells in those tissues.
A chelating agent destabilizes circulating 5′ tRNA halves
Because clotting has the potential to release particles
that are not present in circulating blood, we asked if 5′
tRNA halves circulating in the mouse serum are also
present in mouse plasma. Northern blotting with a 5′
tRNA half probe gave a very weak band in a plasma
sample when compared to the band derived from an
equal volume of serum from the same mouse (Figure 9).
The lack of 5′ tRNA halves in plasma is not due to a
global loss of small RNAs during preparation of the
plasma, which was anticoagulated with EDTA. We used
qPCR to assess the integrity of two circulating miRNAs




















B (5’ probe) C (3’ probe)
Figure 8 Tissue distribution of tRNA-Val-CAC halves. Northern blotting analysis of RNA extracted from the indicated mouse tissues. Blots were
hybridized with 32P-end-labeled oligonucleotide probes complementary to the 5′ (A, B, and D) or 3′ end (C and E) of tRNA-Val-CAC. The positions
of full length tRNAs and tRNA halves are indicated on the right. DM: decade markers.
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three specimens (Figure 10), EDTA does not affect these
circulating miRNAs.
This result could suggest that 5′ tRNA halves are an
artifact of blood clotting, but could also be an effect of
EDTA, a chelating agent that depletes ions required for
clotting. To assess the effects of EDTA on 5′ tRNA
halves, we used Northern blotting to analyse a sample
of serum that was incubated with EDTA for 15 min be-
fore RNA extraction. We also analyzed a sample of
plasma extracted from blood collected with heparin, a
nonchelating anticoagulant. This analysis showed that
treatment of serum with EDTA significantly decreased
the signal corresponding the 5′ tRNA halves, while
5′ tRNA halves are abundant in heparinized plasma
(Figure 9). The same results were obtained with RNAs
from human plasma collected on EDTA and from
serum (Figure 11). These findings suggest that chela-
tion of ions by EDTA destabilizes the complexes carry-
ing 5′ tRNA halves, exposing the RNA to ribonucleases
which are abundant in plasma.Calorie restriction offsets age-associated changes in levels
of specific circulating 5′ tRNA halves
Calorie restriction (CR) can delay, prevent, or reverse
many age-associated changes in physiologic parameters.
We used aging and CR as model physiologic states to ex-
plore the possibility that they are associated with changes
in the levels of circulating 5′ tRNA halves. We performed
pairwise comparisons between young and old control
groups to measure the differential abundance in circulat-
ing 5′ tRNA halves associated with old age, and between
old control and old CR groups to determine whether CR
has an effect on any age-associated changes.
This analysis revealed that aging is associated with alter-
ations, either increase or decrease, in the circulating levels
of 5′ tRNA halves derived from specific tRNA isoacceptors
(Table 3). Notably, CR mitigated most of these age-related
changes (Table 3), although it did not completely prevent
them. CR has been shown to oppose the molecular and
biological markers of aging including alterations in gene
expression [24]. A causal relationship between circulating








Figure 9 Detection of 5′ tRNA halves in mouse plasma and serum. Northern blot of RNAs extracted from 0.4 ml of mouse serum, serum treated
with EDTA, and heparin- or EDTA-collected plasma, hybridized to a 32P 5′-end labeled oligonucleotide probe complementary to the 5′ end of tRNA-
Gly-GCC. EDTA sharply lowers the abundance of 5′ tRNA halves in serum; in plasma, 5′ tRNA halves are abundant when heparin is the anticoagulant,











Figure 10 Real-time PCR amplification plots of circulating miRNAs. Shown are the amplification plots for miR-16 (blue), miR-24 (black), and
the spiked-in miR-Cel-39 (red) measured in mouse serum (A), mouse serum treated with EDTA (B), and mouse plasma collected on EDTA (C). The
y-axis represents the relative fluorescence units (RFU) in a semi-log scale. The x-axis represents the cycle at which fluorescence was detected
above an automatically determined threshold for the indicated miRNA. EDTA does not change the concentration of miRNAs in plasma.










Figure 11 5′ tRNA halves are also present in human serum and
leukocytes, but not in EDTA plasma. RNAs extracted from human
leukocytes, 0.4 ml of human serum, or EDTA-collected plasma. The
northern blot was hybridized to a 32P 5′-end labeled oligonucleotide
probe complementary to the 5′ end of tRNA-Gly-GCC. The positions
of full length tRNAs and tRNA halves are indicated on the right. DM:
decade markers.
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regulated in an age-associated fashion.
Conclusions
Deep sequencing of small RNAs extracted from mouse
serum identifies a population of tRNA-derived mole-
cules, termed 5′ tRNA halves, previously described only
as stress-induced inhibitors of translation initiation in
cultured cells. 5′ tRNA halves are more abundant than
miRNAs in mouse serum, and are derived from distinct
subset of tRNAs by cleavage near the anticodon loop; the
3′ portion of the tRNA molecule is present in serum only
in trace quantities. Ultracentrifugation and size fraction-
ation establish that the 5′ tRNA halves circulate as part
of a larger complex, but are not contained in exosomes
or microvesicles; their sensitivity to the chelating agentEDTA provides further evidence that they exist as circu-
lating nucleoprotein complexes. They are concentrated
in hematopoietic and lymphoid tissues, and present in
other tissues at very low levels that may reflect residual
blood cells. The origin of the serum particles, and their
destinations, are uncertain; however their concentration
in blood cells suggest that they may be produced by these
cells. Levels of serum 5′ tRNA halves are distinctly
changed in aged mice, and calorie restriction inhibits
these changes, indicating that they are subject to physio-
logic regulation. Taken together with the extant evidence
that 5′ tRNA halves can regulate mRNA translation, the
characteristics of the circulating 5′ tRNA halves we have
discovered suggest that they function as signaling mole-
cules with as yet unknown physiologic roles.
To date, the only known function of 5′ tRNA halves is
inhibition of translation in cultured cells subjected to a
variety of stressors; transfection of 5′ tRNA halves in-
hibits global translation in U2OS cells [14,18]. A study
published while this paper was in preparation reported
induction of 5′ tRNA halves in human airway epithelial
cells upon infection with respiratory syncytial virus
(RSV). Induction involves cleavage at the tRNA anti-
codon loop by angiogenin, and at least one type, the 5′
tRNA-Glu-CTC half, promotes RSV replication [25].
Our findings indicate that 5′ tRNA halves function on
an organismal rather than merely a cellular level. Fur-
thermore they are likely to function in a context much
broader than cellular stress or infection: we find 5′
tRNA halves in unstressed conditions. Changes in their
expression (either increased or decreased) with age are
also consistent with a broader physiologic role, and it is
particularly interesting that these changes are partially
mitigated by calorie restriction.
The most extensively studied cellular tRNA halves are
generated under stress conditions by angiogenin, which
cleaves mature tRNAs within the anticodon loops [26].
The stress-induced tRNA halves target the translation initi-
ation machinery to reprogram protein translation in order
to promote cell survival during stress [14,26]. Pull-down
and mass spectrometry analyses of RNA-protein com-
plexes have identified several cellular proteins (YB-1, FXR-
1, and PABP1) bound to intracellular 5′ tRNA halves [14].
The nature of the proteins and/or other factors that bind
and stabilize the extracellular form of 5′ tRNAs halves has
yet to be elucidated. Understanding of the origin, compos-
ition, and destinations of these complexes will provide in-
sights into their role in organismal physiology.
Methods
Serum collection, RNA isolation, and small RNA library
construction
Male mice of the long-lived B6C3F1 strain were fed either
control or calorie-restricted (CR) diet (∼40% fewer calories
Table 3 Age-associated changes in the levels of mouse circulating 5′ tRNA halves and the effects of CR on the
age-associated changes
Age CR
tRNA* Young control † Old control† Old CR† FC‡ p-value FC‡ p-value
His-GTG
chr4:82619623-82619694 797 2988 1554 3.8 3.1E-11 −2 6.8E-04
chr2:122377363-122377434 798 2994 1549 3.8 3.7E-11 −2 6.4E-04
chr3:96452495-96452566 307 1140 590 3.8 3.8E-11 −2 6.1E-04
chr2:122375494-122375565 808 2990 1533 3.8 3.9E-11 −2 5.0E-04
chr2:122377968-122378039 309 1163 600 3.8 4.2E-11 −2 6.6E-04
chr3:96458070-96458141 802 2993 1523 3.8 4.3E-11 −2 4.8E-04
chr3:96500366-96500437 796 2954 1524 3.8 4.5E-11 −2 5.9E-04
chr3:96410069-96410140 301 1148 590 3.9 2.0E-11 −2 5.5E-04
Arg-CCG
chr11:107012866-107012938 1243 256 302 −5 9.9E-12 1.2 4.7E-01
Cys-GCA
chr11:97798906-97798977 933 370 688 −2.6 2.5E-06 1.8 2.4E-03
chr11:97988246-97988317 928 376 700 −2.5 3.9E-06 1.8 2.2E-03
chr11:97988923-97988994 930 360 684 −2.6 1.3E-06 1.9 1.5E-03
Gly-GCC
chr1:171074302-171074372 16868 3739 3807 −4.5 3.5E-14 −1 9.6E-01
chr1:171066631-171066701 16820 3730 3790 −4.5 4.3E-14 −1 9.6E-01
chr1:171081876-171081946 16779 3725 3788 −4.4 5.3E-14 −1 9.6E-01
Lys-CTT
chr17:23533962-23534034 4175 1939 3286 −2.2 8.8E-06 1.7 3.7E-03
chr3:96428235-96428307 4215 1964 3353 −2.2 1.0E-05 1.7 3.3E-03
chr17:23547360-23547432 4098 1923 3272 −2.2 1.1E-05 1.7 3.4E-03
chr17:23535332-23535404 14085 6569 11132 −2.2 1.2E-05 1.7 4.1E-03
chr13:23436340-23436412 4181 1962 3321 −2.2 1.2E-05 1.7 3.9E-03
chr3:96499512-96499584 13865 6507 11017 −2.2 1.3E-05 1.7 3.9E-03
chr11:48833883-48833955 13905 6539 11051 −2.2 1.4E-05 1.7 4.1E-03
Val-AAC
chr13:23401073-23401145 1247 451 814 −2.8 3.3E-07 1.8 4.1E-03
chr13:23413248-23413320 1246 467 836 −2.7 5.4E-07 1.8 4.0E-03
*tRNA isoacceptor identity with corresponding genomic positions of the tRNA genes in the mouse mm10 genome.
†Average tRNA read count for the indicated experimental group reported as counts per million (cpm) reads in the sequenced library from the indicated
experimental group.
‡Fold change calculated by EdgeR from pairwise comparisons between the young and old control groups for the age effect, or between the old control and old
CR groups for the CR effect.
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of three groups: young (7-month) and old (27-month)
mice fed the control diet, and old (27-month) mice
fed the CR diet. Total RNA including small RNA was
isolated from each serum sample with miRNeasy kit
(Qiagen) and used to construct indexed sequencing li-
braries with the Illumina TruSeq Small RNA Sample
Prep Kit. The libraries were pooled and sequenced on
an Illumina HiSeq 2000 instrument to generate 50base reads. Further details about the mice and diets,
and library construction are provided in SI Methods
and Figures.
Mapping and annotation of sequencing reads
Sequencing reads were pre-processed with FASTX-
Toolkit (hannonlab.cshl.edu) to trim the adaptor se-
quences, and discard low quality reads. The obtained
clean reads were mapped to the mouse reference genome
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different combinations of alignment and reporting options.
We used the option ”-n 0 -l 14“ to align the sequencing
reads according to a policy similar to Maq‘s default policy
and requiring no mismatches in the first 14 bases (the
high-quality end of the read). In addition, this mode of
alignment was combined with options that define which
and how many alignments should be reported; the option
“-k 1 --best” instructed bowtie to report only the best align-
ment if more than one valid alignment exists, while the op-
tion “-m 1” instructed bowtie to refrain from reporting any
alignments for reads having multiple reportable align-
ments. The “-k 1 --best” and “-m 1” modes of alignment
reporting were also used in combination with the end-
to-end k-difference (−v) alignment mode. Varying the
alignment and reporting modes allowed the differential de-
tection of two predominant peak sizes of sequencing reads
as described in the results section.
Annotation analysis of the mapped sequencing reads
was performed with bedtools [27] using the following
databases: the Genomic tRNA Database [19] (gtrnadb.
ucsc.edu), miRBase 18 (mirbase.org), and rRNA, snRNA,
scRNA, and srpRNA which were extracted from the
RepeatMasker track (genome.ucsc.edu; mm10).
Analysis of differentially abundant circulating tRNA halves
The bowtie alignment files generated above from the
young and old control and old CR serum sequencing
samples were analyzed with bedtools [27] to obtain the
coverage of the tRNA genes included in the Genomic
tRNA Database [19] (gtrnadb.ucsc.edu), and to deter-
mine the read count for each tRNA in the database. The
tRNA read counts were further analyzed with the
Bioconductor package edgeR [28] to detect the changes
in the levels of circulating 5′ tRNA halves in the different
experimental groups. The algorithm of edgeR fits a nega-
tive binomial model to the count data, estimates disper-
sion, and measures differences using the generalized linear
model likelihood ratio test which is recommended for ex-
periments with multiple factors, such as the simultaneous
analysis of age and diet in our study. The fitted count data
was analyzed by performing pairwise comparisons between
the different experimental groups: young and old control
groups were compared to measure the differential abun-
dance in circulating 5′ tRNA halves associated with old
age; old control and old CR groups were compared to de-
termine whether CR has an effect on any age-associated
changes. The results were further filtered to keep only 5′
tRNA halves that achieved a minimum of 500 counts per
million (cpm) in at least one of the 3 experimental groups.
Northern blot assays
RNAs analyzed with Northern blots were extracted from
normal or sodium arsenite-treated U2OS and from avariety of tissues and sera harvested from one-year-old
mice fed control diet. Before RNA extraction, some
serum samples were centrifuged at 110000 g for 2 hrs,
and supernatant and pellet fractions were separated, or
were separated into concentrate and filtrate fractions by
ultrafiltration through Vivaspin 2 columns with 30, 100,
or 300 kDa MW cut-off. RNAs were separated on 15%
denaturing polyacrylamide gels, transferred and fixed to a
membrane by chemical cross-linking [29], and hybridized
with probes complementary to 5’ and 3′ ends of tRNAs.
Further details about Northern blot assays, and probe se-
quences are provided in SI Methods and Figures.
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Additional file 1: Additional Methods and Figures S1 and S2.
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